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Editorial Comment
Eliminating inappropriate shocks is one of the most vex-
ing challenges for clinicians and patients with implantable
cardioverter-defibrillators (ICD). Though a frustration for
physicians, inappropriate shocks are a source of despair and
fear for patients. Inappropriate shocks often lead to burden-
some emergency rooms visits, medication changes or in-
terventions such as atrioventricular node ablation or device
modifications.
Inappropriate therapies were once seen as an unavoidable
price for a life-saving technology. However, we are learning
that ICD shocks are associated with significant anxieties and
depression, and perhaps reduced survival.1 The associated
increase in posttraumatic stress, anxiety, and depression, of-
ten brings desperate patients to request that all of their ICD
therapies be disabled.
Technological advances and the use of ICDs in younger,
more vital patients bring the reasonable expectation that in-
appropriate therapies—especially shocks—should be mini-
mized if not eliminated. Early methods such as simple rate
cutoff adjustments and measurements of rate stability have
evolved to analysis of the electrogram morphology or the
atrioventricular relationship of a given arrhythmia.
Two philosophies guide the decision to place an atrial
lead to employ atrioventricular detection algorithms. First,
some physicians routinely place an atrial lead in their ICD
patients to hopefully reduce inappropriate shocks in a pop-
ulation with high rates of atrial arrhythmias. This is usually
simple and involves a small increase in procedure time. How-
ever, there may be short- and long-term consequences of hav-
ing these additional components. An analysis of the National
Cardiovascular Data Registry (NCDR) demonstrated a 45%
increase in complications in patients receiving dual-chamber
versus single-chamber ICDs.2 Additionally, as patients live
longer with heart disease, they are surviving beyond the lifes-
pan of their ICD components. With this comes lead replace-
ments or extractions for both the inevitable and unexpected
breakdown of these components. Recent lead recalls have
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heightened our awareness of the long-term vulnerabilities of
implantable ICD leads. These concerns have led implanters
to take the opposite course by avoiding atrial lead place-
ment unless there are established pacing indications. These
differing practices raise an important question: Should dual-
chamber ICDs be routinely placed to reduce inappropriate
therapies?
This brings us to the report by Ruwald et al. in the current
issue of the Journal of Cardiovascular Electrophysiology.3
In this study, the authors used data from the Multicenter Au-
tomatic Defibrillator Implantation With Cardiac Resynchro-
nization Therapy (MADIT-CRT) study to determine if dual-
chamber ICDs reduced inappropriate therapies compared
with single-chamber ICDs. They did this by analyzing 704
patients who received ICD therapy without cardiac resyn-
chronization therapy. Of these, 410 received dual-chamber
ICDs and 294 received single-chamber ICDs. The choice of
device was at the discretion of the implanting physician. Over
a 5-year follow-up period, there were 91 inappropriate ther-
apies, and the use of dual-chamber ICDs was not associated
with a reduced risk of inappropriate therapies. Perhaps due to
the low number of events, there was a trend to a risk reduction
in ICD shocks and shocks from atrial arrhythmias that did
not meet statistical significance. There was no difference in
mortality or complications from the implant procedure. The
authors conclude that the empiric addition of an atrial lead
does not reduce inappropriate therapies from ICDs, though
they acknowledge the trend of reduced shocks.
Ruwald’s study is the largest comparing the rate of
inappropriate therapies between single-chamber and dual-
chamber ICDs, and the study’s design and findings have
both insights and limitations. Since the patients could not
have had atrial arrhythmias within 1 month of implant, we
can speculate that the study population has a lower atrial ar-
rhythmia burden. The decision to place the atrial lead in the
study population was at the discretion of implanting physi-
cian, suggesting a “real world” view of the implant trends
for dual chamber devices. Despite the large sample size, the
trend to reduced inappropriate shocks in dual-chamber de-
vices did not reach statistical significance in this population.
Though a larger sample size may reveal such a difference,
one can question if this would be clinically relevant to change
one’s practice.
The study does have limitations. The study population was
not randomized, which prevents us from viewing these results
with the strictest scientific rigor. As a subset of MADIT-
CRT, the study was not designed or powered to answer the
question proposed by Ruwald. The burden of asymptomatic
atrial arrhythmias could be underestimated since this was not
preoperatively assessed. Since only one manufacturer was
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used, other atrioventricular discriminator algorithms could
not be evaluated. Finally, the particulars of the algorithm
settings were not available to the investigators to determine
if they were optimized.
The recent publication in Multicenter Automatic Defib-
rillator Implantation Trial - Reduce Inappropriate Therapy
(MADIT-RIT) also shows us that reducing inappropriate
shocks can be achieved by simply increasing an ICD’s rate
cutoff or detection time. In this study, inappropriate thera-
pies in the 2 treatment arms were approximately 4% with
demonstrated mortality reductions in the 2 treatment arms.4
Since this is less than half the rate of inappropriate shocks
found in the Ruwald study, we can speculate that with this
strategy, an even larger study population would be nec-
essary to determine the justification of empiric atrial lead
placement.
From the results of Ruwald and other studies, the decision
to place an empiric atrial lead to reduce inappropriate thera-
pies should be individualized to particular circumstances of
the patient. For patients with a history of atrial arrhythmias
and rapid ventricular rates, placement of an atrial lead may be
helpful. However, from the report by Ruwald, MADIT-RIT
and others, the routine use of atrial lead placement to sim-
ply reduce inappropriate shocks is not justified. A recently
released defibrillator lead with an integrated atrial sensing
electrode (VDD-ICD) could give us the “best of both worlds,”
having the advantages of available atrial electrograms with-
out additional intravascular hardware.
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